View all cases
- Case details
- Status—ActionProcedural applicationCategoryOther procedural
- Parties
- Claimants
- Merz Therapeutics GmbHOperating co.
- Merz Pharmaceuticals LLCOperating co.
- Merz Pharma FranceOperating co.
Representatives- Laëtitia Bénard-A&O Shearman
- Division
- Paris LD
- Technology
- ChemistryPharmaceuticals
- Language
- —
- First decided
- Sep 17, 2025
- EPO Opposition
- Actavis Group PTC ehfAdmissible2013-12-05
- Synthon B.V.Admissible2013-12-06
- neuraxpharm Arzneimittel GmbHAdmissible2013-12-06
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Paris LD | Locked |
| Judge Camille Lignières | Locked |
| Judge Carine Gillet | Locked |
| Judge Samuel Granata | Locked |
| Judge Rainer Friedrich | Locked |
At the UPC: Merz Therapeutics GmbH (6 cases)·Viatris Santé (6 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 5 other proceedings
UPC CFI 3259/2026·UPC CFI 1901/2026·UPC CoA 917/2025·UPC CoA 906/2025·UPC CFI 697/2025
1 other defendants litigating the same or a related patent
Decisions
- 2025-09-17
Summary: Paris Local Division order (judge-rapporteur Lignières, full panel) in provisional measures proceedings by Merz Therapeutics GmbH and related Merz entities against Viatris Santé concerning EP 2 377 536 (botulinum toxin / SPC FR13C0033). The order addresses Merz's procedural application (R. 9 RoP) to limit or restructure Viatris' 473-page objection, or alternatively to set a page limit for subsequent submissions. No substantive ruling on the provisional measures application.
Show the legal issues (3)
- Provisional measures procedural application (R. 9 RoP)
- Page limit for pleadings
- Botulinum toxin / SPC patent
Documents
- AC4973CA712413DEAB319A4B24F99249_en.pdf2025-09-17EN